Chengfei Liu
- University of California at Davis · Urology (NIH department code)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
FY2024 NIH rank #17,657
- R01 Holder
- Early Career
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12621986Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-2452-8788Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Urology
NIH Funding · FY2024
Linked Award Amount
$864.1K
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#17,657
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Chengfei Liu as a PI. Multi-PI records show the full award amount for context.
- 5R01CA251253-04R01Contact PIModulating HSP70/STUB1 machinery in therapy-resistant prostate cancerUniversity of California at Davis · Urology (NIH department code)$344.1Kaward amount
- 5R37CA249108-04R37Contact PIDissecting the Role of Proteostasis in Anti-Androgen Resistant Prostate CancerUniversity of California at Davis · Urology (NIH department code)$341.2Kaward amount
- 5R21CA277171-02R21Contact PITargeting intracrine steroidogenesis in anti-androgen resistant prostate cancerUniversity of California at Davis · Urology (NIH department code)$178.8Kaward amount
Award organization
Organizations that administered FY2024 awards listing Chengfei Liu as a PI.
FY2024 award administered by University of California at Davis (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of California at Davis
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding